期刊文献+

细胞外基质金属蛋白酶诱导因子和尿激酶型纤溶酶原激活物在载脂蛋白E基因敲除小鼠主动脉粥样硬化斑块中的表达 被引量:10

Expression of Extracellular Matrix Metalloproteinase Inducer and Urokinase-Type Plasminogen Activator in Aortic Atherosclerotic Plaques of ApoE Knockout Mice
下载PDF
导出
摘要 目的探讨细胞外基质金属蛋白酶诱导因子(EMMPRIN)与尿激酶型纤溶酶原激活物(uPA)在载脂蛋白E基因敲除(ApoE-/-)小鼠主动脉粥样硬化斑块中的表达,并探讨两者的相互关系。方法研究对象采用ApoE-/-小鼠,共喂养18周,分别于6周、10周、14周和18周4个时间点处死小鼠行HE染色切片观察动脉粥样硬化斑块形态;并采用RT-PCR及Western blot检测主动脉粥样硬化斑块内EMMPRIN和uPA的表达。结果成功建立动脉粥样硬化模型;在主动脉粥样硬化斑块中检测到EMMPRIN和uPA表达均增高,与普通饮食组比较有统计学意义(P<0.05)。EMMPRIN和uPA表达随喂养时间延长而增高。结论 EMMPRIN和uPA在ApoE-/-小鼠主动脉粥样硬化斑块中随着斑块病变程度的严重性增加表达增高,两者可能共同参与粥样硬化斑块的发生发展过程。 Aim To investigate the expression of extracellular matrix metalloproteinase inducer(EMMPRIN) and urokinase-type plasminogen activator(uPA) in aortic atherosclerotic plaques of apolipoprotein E knockout(ApoE-/-) mice and to explore the relationship between the two.Methods ApoE-/-mice were randomized into ordinary diet fed group and high-fat diet fed group,raising for 18 weeks.At 6 weeks,10 weeks,14 weeks,18 weeks mice were sacrificed and observed by HE staining of atherosclerotic plaque morphology.EMMPRIN and uPA expression in aortic atherosclerotic plaques were detected by semi-quantity RT-PCR and Western blot.Rusults Atherosclerosis model was successfully established;EMMPRIN and uPA in aorta atherosclerotic plaques were highly expressed,with statistically significant difference from normal diet group(P〈0.05).Expression of EMMPRIN and uPA increased with feeding time extended.Conclusion Expression of EMMPRIN and uPA in ApoE-/-mice aortic atherosclerosis increased with plaque lesions degree of severity, both ofEMMPRIN and uPA may play a role in the atherosclerotic plaques development.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第8期673-677,共5页 Chinese Journal of Arteriosclerosis
基金 成都军区医学科研"十一五"计划课题(MB09029)
关键词 细胞外基质金属蛋白酶诱导因子 尿激酶型纤溶酶原激活物 动脉粥样硬化 不稳定性斑块 载脂蛋白E基因敲除小鼠 Extracellular Matrix Metalloproteinase Inducer Urokinase-Type Plasminogen Activator Athero-sclerosis Vulnerable Plague Apolipoprotein E Knockout Mice
  • 相关文献

参考文献15

  • 1Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-de- rived collagenase stimulatory factor (renamed EMMPRIN ) is a member of the immunoglobulin superfamily[ J]. Cancer Res, 1995, 55 : 434-439.
  • 2Huet E, Gabison EE, Mourah S, et al. Role of EMMPRIN/CD147 in tissue remodeling[J]. Connect Tissue Res, 2008,49: 175-179.
  • 3Schmidt R, Bultmann A, Fischel S, et al. Extracellular matrix met- alloproteinase inducer (CD147) is a novel receptor on platelets, ac- tivates platelets, and augments nuclear factor kappaB-dependent in- flammation in monocytes[ J]. Circ Res, 2008, 102 : 302-309.
  • 4Huang Z, Wang C, Wei L, et al. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-indueed THP-1 cells[ J ]. Biochem Biophys Res Commun, 2008, 374 : 517-521.
  • 5Major TC, Liang L, Lu X, et al. Extracellular matrix metallop rotei- nase inducer(EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma[ J]. Arterioscler Thromb Vasc Biol, 2002, 22(7) :1 200-207.
  • 6Steins MB, Padro T, Schwaenen C, et al. Overexpression of uroki- nase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic le- sions[J]. Blood Coagul Fibrinolysis, 2004, 15: 383-391.
  • 7Salame MY, Samani N J, Masood I, et al. Expression of the plas- minogen activator system in the human vascular wall [ J ]. Athero- sclerosis, 2000, 152 : 19-28.
  • 8Quemener C, Gabison EE, Naimi B, et al. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasmino- gen activator system promoting tumor cell invasion [ J ]. Cancer Res, 2007, 67: 9-15.
  • 9Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer inter- actions[J]. Cancer Res, 2001,61 (5) : 2 276-281.
  • 10Kim JY, Kim WJ, Kim H, et al. The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages:im- plication for atherosclerosis[J]. Immume Netw, 2009, 9(3) : 90-97.

同被引文献76

  • 1范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 2何清,王长谦,葛恒,郭炳诗,何奔.特异性抑制单核细胞中EMMPRIN基因表达的siRNA筛选和鉴定[J].上海交通大学学报(医学版),2007,27(6):681-684. 被引量:5
  • 3FUHRMAN B. The urokinase system in the pathogenesis of atherosclerosis[J]. Atherosclerosis, 2012,222( 1 ) : 8-14.
  • 4PAWLAK K, MYSLIWIEC M, PAWLAK D. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients[J]. Thromb Res, 2008, 122(3) : 328-335.
  • 5SVENSSON P A, OLSON F J type plasminogen activator HAGG D A, et al. Urokinase- receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis [ J ]. Int J Mol Med, 2008,22 (4) : 459-464.
  • 6HU J I-I, DU L, CHU T, et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice[J]. Circulation, 2010,121 (14) : 1637-1644.
  • 7FARRIS S D, HU J H, KRISHNAN R, et al. Mechanisms of urokinase plasminogen activator ( uPA ) -mediated atheroselerosis: role of the aPA receptor and SIOOA8/A9 proteins [ J ]. J Biol Chem, 2011,286 (25) : 22665-22677.
  • 8STEPANOVA V, LEBEDEVA T, KUO A, et al. Nuclear translocation of urokinase-type plasminogen activator [ J ]. Blood, 2008,112(1): 100-110.
  • 9REICHEL C A, KANSE S M, KROMBACH F. At theinterface of fibrinolysis and inflammation : the role of urokinase- type plasminogen activator in the leukocyte extravasation cascade[J]. Trends Cardiovasc Med, 2012, 22(7): 192-196.
  • 10PLEKHANOVA O, BERK B C, BASHTRYKOV P, et al. Oligonucleotide microarrays reveal regulated genes related to inward arterial remodeling induced by urokinase plasminogen activator[J]. J Vase Res, 2009, 46(3) : 177-187.

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部